1-6 of 6
E Randolph Broun
Close
Sort by
Journal Articles

Trial in Progress: Asciminib in Monotherapy 4 CML (AIM4CML), a Phase IIIb Study of Asciminib Monotherapy in Patients with Chronic Myeloid Leukemia in Chronic Phase without or with T315I Mutations

David Andorsky, Sarah Tomassetti, Yehuda E. Deutsch, E Randolph Broun, Ghayas C. Issa, Moshe Y. Levy, Michael W. Deininger, Rodrigo Maegawa, Alok Shrestha, Michael J. Mauro
Journal: Blood
Blood (2021) 138 (Supplement 1): 3599.
https://doi.org/10.1182/blood-2021-147337
Published: 2021
Journal Articles

Treatment Initiation of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in Patients with Untreated Acute Myeloid Leukemia

Sudhir Manda, Bertrand Anz, III, Christopher Benton, E. Randolph Broun, Habte Yimer, John Renshaw, George F. Geils, Jr., Jose Cruz, Suzanne Fanning, Jason Melear, Jeff P. Sharman, Kingston Kang, Anders Svensson, Madhavi Pai, William Donnellan
Journal: Blood
Blood (2021) 138 (Supplement 1): 1265.
https://doi.org/10.1182/blood-2021-144886
Published: 2021
Journal Articles

Importance of Achieving Complete Remission (CR) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults Age ≥60 Years: Analysis of Risk Factors for Early Mortality and Re-Induction, and Impact of Quality of Response on Overall Survival (OS) in the ECOG-ACRIN E2906 Randomized Trial

James M. Foran, MD, Zhuoxin Sun, PhD, David F. Claxton, MD, Hillard M. Lazarus, MD, Mary L. Thomas, RN, MS, Ari Melnick, MD, Ross L. Levine, MD, Elisabeth Paietta, PhD, Daniel A. Arber, MD, Yanming Zhang, MD, Jacob M. Rowe, MD, John E. Godwin, Jessica K Altman, MD, Selina Luger, MD, Aref Al-Kali, MD, Hong Zheng, MD PhD, Keith W. Pratz, MD, E. Randolph Broun, MD, Bayard L Powell, MD, Kristen O'Dwyer, MD, Mark Litzow, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2016) 128 (22): 339.
https://doi.org/10.1182/blood.V128.22.339.339
Published: 2016
Journal Articles

North American Leukemia, Intergroup Phase III Randomized Trial of Single Agent Clofarabine As Induction and Post-Remission Therapy, and Decitabine As Maintenance Therapy in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age ≥60 Years): A Trial of the ECOG-ACRIN Cancer Research Group (E2906)

James M. Foran, MD, Zhuoxin Sun, PhD, David F. Claxton, MD, Hillard M. Lazarus, MD, Mary L. Thomas, RN, MS, Ari Melnick, MD, Ross L. Levine, MD, Elisabeth Paietta, PhD, Daniel Arber, Yangming Zhang, MD, Jacob M. Rowe, MD, John E. Godwin, MD MS, Jessica K. Altman, MD, Selina Luger, MD, Aref Al-Kali, MD, Hong Zheng, MD PhD, Keith Pratz, MD, E. Randolph Broun, MD, Bayard L. Powell, MD, Kristen O'Dwyer, MD, Mark R Litzow, MD, Martin S Tallman, MD
Journal: Blood
Blood (2015) 126 (23): 217.
https://doi.org/10.1182/blood.V126.23.217.217
Published: 2015
Journal Articles

A Randomized Phase II Trial of Three Novel Regimens for Relapsed/ Refractory Acute Myeloid Leukemia (AML) Demonstrates Encouraging Results with a Flavopiridol-Based Regimen: Results of Eastern Cooperative Oncology Group (ECOG) Trial E1906

Mark R. Litzow, MD, Xin Victoria Wang, PhD, Martin P. Carroll, MD, Judith E. Karp, MD, Rhett Ketterling, MD, Scott H. Kaufmann, MD PhD, Hillard M. Lazarus, Selina M. Luger, MD, Elisabeth M. Paietta, PhD, Jacob M. Rowe, MD, Jessica K Altman, Keith W Pratz, MD, E. Randolph Broun, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2014) 124 (21): 3742.
https://doi.org/10.1182/blood.V124.21.3742.3742
Published: 2014
Journal Articles

A Rare Cause of Anemia in Inflammatory Bowel Diseases: A Case Report and Review of Literature

Waqas Ahmed, MD, Kevin Monroe, MD, James Essell, MD, E. Randolph Broun, MD
Journal: Blood
Blood (2008) 112 (11): 5385.
https://doi.org/10.1182/blood.V112.11.5385.5385
Published: 2008